Home/Bausch Health/Robert Spurr
RS

Robert Spurr

President, Salix Pharmaceuticals

Bausch Health

Bausch Health Pipeline

DrugIndicationPhase
XIFAXAN (rifaximin)Pediatric Irritable Bowel Syndrome with Diarrhea (IBS-D)Phase 3
AmiselimodModerate to Severe Ulcerative ColitisPhase 2
RelamorelinDiabetic GastroparesisPhase 2